MidWestOne Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
+389
| New | +$204K | 0.03% | 281 |
|
|
2022
Q4 | – | Sell |
-1,123
| Closed | -$774K | – | 249 |
|
|
2022
Q3 | $774K | Sell |
1,123
-5
| -0.4% | -$3.45K | 0.2% | 123 |
|
|
2022
Q2 | $667K | Sell |
1,128
-22
| -2% | -$13K | 0.17% | 131 |
|
|
2022
Q1 | $803K | Buy |
1,150
+35
| +3% | +$24.4K | 0.17% | 135 |
|
|
2021
Q4 | $704K | Buy |
1,115
+131
| +13% | +$82.7K | 0.15% | 151 |
|
|
2021
Q3 | $595K | Buy |
984
+26
| +3% | +$15.7K | 0.14% | 146 |
|
|
2021
Q2 | $535K | Sell |
958
-19
| -2% | -$10.6K | 0.13% | 149 |
|
|
2021
Q1 | $462K | Buy |
977
+414
| +74% | +$196K | 0.11% | 155 |
|
|
2020
Q4 | $272K | Sell |
563
-239
| -30% | -$115K | 0.07% | 180 |
|
|
2020
Q3 | $449K | Buy |
+802
| New | +$449K | 0.15% | 149 |
|